Management of Raynaud's phenomenon and digital ischemia.

Management of Raynaud's phenomenon and digital ischemia.

Item
http://www.wikidata.org/entity/Q38071979
Melanopsin mediates light-dependent relaxation in blood vessels.Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.The cardiac magnetic resonance in the diagnosis of cardiac Raynaud phenomenon in a patient with systemic sclerosis: case report and review of literature.Innominate Artery Stenosis Presenting With Migratory Digital Ischemia.Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.Endothelial dysfunction, microvascular damage and ischemic peripheral vasculopathy in systemic sclerosis.Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study.A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol
P2860

Management of Raynaud's phenomenon and digital ischemia.

Item
http://www.wikidata.org/entity/Q38071979
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of Raynaud's phenomenon and digital ischemia.
@en
type
label
Management of Raynaud's phenomenon and digital ischemia.
@en
prefLabel
Management of Raynaud's phenomenon and digital ischemia.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Management of Raynaud's phenomenon and digital ischemia.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698